@article{95d33e2a4e2c4484ae47f1462845b73a,
title = "Three-Year Survival Results From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Systemic Anaplastic Large Cell Lymphoma",
author = "Advani, \{Ranjana H.\} and Pauline Brice and Bartlett, \{Nancy L.\} and Rosenblatt, \{Joseph D.\} and Tim Illidge and Jeffrey Matous and Radhakrishnan Ramchandren and Fanale, \{Michelle A.\} and Connors, \{Joseph M.\} and Yin Yang and Dirk Huebner and Kennedy, \{Dana A.\} and Shustov, \{Andrei R.\}",
note = "624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster I | Barbara Pro, Ranjana H. Advani, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle A. Fanale, Joseph M. Connors, Yin Yang, Dirk Huebner, Dana A. Kennedy, Andrei R.",
year = "2013",
month = nov,
day = "15",
doi = "10.1182/BLOOD.V122.21.1809.1809",
language = "American English",
volume = "122",
journal = "Blood",
publisher = "American Society of Hematology",
number = "21",
}